Cargando…
Real-world Assessment of 2879 COVID-19 Patients Treated With Monoclonal Antibody Therapy: A Propensity Score–Matched Cohort Study
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread globally and cause significant morbidity and mortality. Antispike protein monoclonal antibody (mAb) therapy has been shown to prevent progression to severe coronavirus disease 2019 (COVID-19). The objective...
Autores principales: | Cooper, Megan H, Christensen, Paul A, Salazar, Eric, Perez, Katherine K, Graviss, Edward A, Nguyen, Duc, Musser, James M, Huang, Howard J, Liebl, Michael G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088516/ https://www.ncbi.nlm.nih.gov/pubmed/35559124 http://dx.doi.org/10.1093/ofid/ofab512 |
Ejemplares similares
-
Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force
por: Tanaka, Hiromu, et al.
Publicado: (2023) -
Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study
por: Steere, Evan L, et al.
Publicado: (2023) -
Corticosteroid Therapy for Patients With Severe Fever With Thrombocytopenia Syndrome: A Nationwide Propensity Score–Matched Study in Japan
por: Shuto, Hisayuki, et al.
Publicado: (2023) -
Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
por: Laidler, Matthew R., et al.
Publicado: (2015) -
Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis
por: Madden, Gregory R, et al.
Publicado: (2020)